Hematologic and molecular response to ropeginterferon alfa-2b in patients with polycythemia vera: a systematic review and meta-analysis
Abstract Ropeginterferon alfa-2b is an interferon used in the treatment of myeloproliferative neoplasms, particularly polycythemia vera. Its efficacy in achieving hematologic and molecular responses has been demonstrated in clinical trials, but pooled data on long-term outcomes and sustained respons...
Kaydedildi:
| Asıl Yazarlar: | , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Springer
2026-05-01
|
| Seri Bilgileri: | Annals of Hematology |
| Konular: | |
| Online Erişim: | https://doi.org/10.1007/s00277-026-07005-0 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|